The viability and growth of EBV-positive Burkitt lymphoma Akata cells were suppressed by simultaneous anti-IgG treatment and m6A modification blockade, either by KO of METTL3 (Figure 4) or by inhibitors of m6A modification (Figures 6, 8). This evidence concerns the gene METTL3 and Burkitt lymphoma.